Campbell J W, Pollack I F
Department of Neurological Surgery, Children's Hospital of Pittsburgh, USA.
J Neurooncol. 1996 May-Jun;28(2-3):223-31. doi: 10.1007/BF00250201.
Cerebellar astrocytomas, as a group, carry a more favorable prognosis than most other brain tumors, because these neoplasms generally are histologically benign and amenable to extensive resection. However, it is clear that a number of factors have an impact on prognosis. In particular, resection extent has been strongly associated with progression-free survival: patients undergoing gross total resection appear to have a substantially better prognosis than those undergoing incomplete resection. Brainstem invasion, which is the factor that most often precludes a complete resection, has also been associated with a less favorable prognosis. In addition, histological features indicative of malignancy are clearly associated with a poor outcome. In contrast to the above observations, which have been established convincingly in the literature, a number of issues regarding cerebellar astrocytomas remain unresolved. First, the correlation between histology and prognosis among patients with low-grade cerebellar astrocytomas is uncertain: in some series, pilocytic astrocytomas have been associated with a better prognosis than non-pilocytic tumors, but in other studies, no such relationship has been observed. Second, the role of radiotherapy after incomplete resection of a low-grade cerebellar astrocytoma remains problematic. In view of the lack of convincing data in this regard, many groups, including our own, defer radiotherapy until there is evidence of progressive disease that is surgically unresectable. Finally, the frequency of follow-up in patients with cerebellar astrocytomas remains largely empirical. Although most recurrences are detected within a few years after initial surgery, late recurrences are well known, which raises the question of when and if such patients should be regarded as "cured' of their disease. Long-term multi-institutional natural history studies are in progress to address the above issues.
作为一个群体,小脑星形细胞瘤的预后比大多数其他脑肿瘤更有利,因为这些肿瘤在组织学上通常是良性的,并且适合进行广泛切除。然而,显然有许多因素会影响预后。特别是,切除范围与无进展生存期密切相关:接受全切除的患者预后似乎明显优于接受不完全切除的患者。脑干侵犯是最常妨碍完全切除的因素,也与较差的预后相关。此外,提示恶性的组织学特征显然与不良结局相关。与文献中令人信服地确立的上述观察结果相反,关于小脑星形细胞瘤的一些问题仍未解决。首先,低级别小脑星形细胞瘤患者的组织学与预后之间的相关性尚不确定:在一些系列研究中,毛细胞型星形细胞瘤的预后比非毛细胞型肿瘤更好,但在其他研究中,未观察到这种关系。其次,低级别小脑星形细胞瘤不完全切除后放疗的作用仍然存在问题。鉴于这方面缺乏令人信服的数据,包括我们自己在内的许多研究小组将放疗推迟到有证据表明存在手术无法切除的进行性疾病时。最后,小脑星形细胞瘤患者的随访频率在很大程度上仍然是经验性的。虽然大多数复发在初次手术后几年内被发现,但晚期复发是众所周知的,这就提出了何时以及这些患者是否应被视为疾病“治愈”的问题。正在进行长期的多机构自然史研究以解决上述问题。